{"disease":{"id":"atd","name":"atd"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07152834","title":"Screening for Alpha-1 Antitrypsin Deficiency in Patients With Airway Obstruction","phase":"","overall_status":"RECRUITING","enrollment_count":734,"lead_sponsor_name":"Muğla Sıtkı Koçman University","has_results":false},{"nct_id":"NCT01851642","title":"Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs","phase":"","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"University of Florida","has_results":false},{"nct_id":"NCT03679598","title":"Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":true},{"nct_id":"NCT07242079","title":"Effect Of Pulmonary Rehabilitation in Patients With Alpha-1 Antitrypsin Deficiency","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"University of Parma","has_results":false},{"nct_id":"NCT04143841","title":"Viveye Ocular Magnetic Neurostimulation System (OMNS) for the Management of Severe Dry Eye Disease","phase":"NA","overall_status":"TERMINATED","enrollment_count":50,"lead_sponsor_name":"Epitech Mag Ltd.","has_results":false},{"nct_id":"NCT05315921","title":"Study of OsrhAAT or Placebo in Healthy Volunteers","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":48,"lead_sponsor_name":"Healthgen Biotechnology Corp.","has_results":false},{"nct_id":"NCT06186492","title":"A Phase 1 Research Study to Evaluate Safety, Tolerability, and Pharmacokinetics of WVE-006 in Healthy Participants With Wild-type AAT Expression (RestorAATion-1)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Wave Life Sciences Ltd.","has_results":true},{"nct_id":"NCT06677307","title":"A Phase 1/2a, Single- and Multiple-dose Escalation Study of KRRO-110","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":42,"lead_sponsor_name":"Korro Bio, Inc.","has_results":false},{"nct_id":"NCT03815396","title":"Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Inhibrx Biosciences, Inc","has_results":false},{"nct_id":"NCT06622668","title":"NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Intellia Therapeutics","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}